242 related articles for article (PubMed ID: 32885602)
21. Histone deacetylase 6 inhibition restores autophagic flux to promote functional recovery after spinal cord injury.
Zheng Z; Zhou Y; Ye L; Lu Q; Zhang K; Zhang J; Xie L; Wu Y; Xu K; Zhang H; Xiao J
Exp Neurol; 2020 Feb; 324():113138. PubMed ID: 31794745
[TBL] [Abstract][Full Text] [Related]
22. HDAC6 deacetylation of tubulin modulates dynamics of cellular adhesions.
Tran AD; Marmo TP; Salam AA; Che S; Finkelstein E; Kabarriti R; Xenias HS; Mazitschek R; Hubbert C; Kawaguchi Y; Sheetz MP; Yao TP; Bulinski JC
J Cell Sci; 2007 Apr; 120(Pt 8):1469-79. PubMed ID: 17389687
[TBL] [Abstract][Full Text] [Related]
23. HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness.
Leyk J; Daly C; Janssen-Bienhold U; Kennedy BN; Richter-Landsberg C
Cell Death Dis; 2017 Aug; 8(8):e3028. PubMed ID: 29048427
[TBL] [Abstract][Full Text] [Related]
24. Modification of cardiac disease by transgenically altered histone deacetylase 6.
Sanbe A; Inomata Y; Matsushita N; Sawa Y; Hino C; Yamazaki H; Takanohashi K; Takahashi N; Higashio R; Tsumura H; Aoyagi T; Hirose M
Biochem Biophys Res Commun; 2022 Nov; 631():48-54. PubMed ID: 36166953
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux.
Jin J; Gong J; Zhao L; Zhang H; He Q; Jiang X
J Diabetes; 2019 Oct; 11(10):826-836. PubMed ID: 30864227
[TBL] [Abstract][Full Text] [Related]
26. Histone deacetylase 6 (HDAC6) deacetylates extracellular signal-regulated kinase 1 (ERK1) and thereby stimulates ERK1 activity.
Wu JY; Xiang S; Zhang M; Fang B; Huang H; Kwon OK; Zhao Y; Yang Z; Bai W; Bepler G; Zhang XM
J Biol Chem; 2018 Feb; 293(6):1976-1993. PubMed ID: 29259132
[TBL] [Abstract][Full Text] [Related]
27. [Inhibition of Histone Deacetylase 6 Ameliorates Podocyte Injury in Diabetic Kidney Disease in Mice].
Hou Q; Kan S; Zhang M; Xu F; Liu Z; Jiang S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1097-1104. PubMed ID: 38162083
[TBL] [Abstract][Full Text] [Related]
28. Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema.
Yu J; Ma Z; Shetty S; Ma M; Fu J
Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L39-47. PubMed ID: 27190059
[TBL] [Abstract][Full Text] [Related]
29. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J
Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545
[TBL] [Abstract][Full Text] [Related]
30. Role of transcription factor acetylation in diabetic kidney disease.
Liu R; Zhong Y; Li X; Chen H; Jim B; Zhou MM; Chuang PY; He JC
Diabetes; 2014 Jul; 63(7):2440-53. PubMed ID: 24608443
[TBL] [Abstract][Full Text] [Related]
31. Tubulin hyperacetylation is adaptive in cardiac proteotoxicity by promoting autophagy.
McLendon PM; Ferguson BS; Osinska H; Bhuiyan MS; James J; McKinsey TA; Robbins J
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):E5178-86. PubMed ID: 25404307
[TBL] [Abstract][Full Text] [Related]
32. HDAC6 is a microtubule-associated deacetylase.
Hubbert C; Guardiola A; Shao R; Kawaguchi Y; Ito A; Nixon A; Yoshida M; Wang XF; Yao TP
Nature; 2002 May; 417(6887):455-8. PubMed ID: 12024216
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase 6 (HDAC6) is an independent deacetylase for alpha-tubulin.
Zhao Z; Xu H; Gong W
Protein Pept Lett; 2010 May; 17(5):555-8. PubMed ID: 19961433
[TBL] [Abstract][Full Text] [Related]
34. Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6.
Zilberman Y; Ballestrem C; Carramusa L; Mazitschek R; Khochbin S; Bershadsky A
J Cell Sci; 2009 Oct; 122(Pt 19):3531-41. PubMed ID: 19737819
[TBL] [Abstract][Full Text] [Related]
35. HDAC6 inhibitor accelerates wound healing by inhibiting tubulin mediated IL-1β secretion in diabetic mice.
Karnam K; Sedmaki K; Sharma P; Routholla G; Goli S; Ghosh B; Venuganti VVK; Kulkarni OP
Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165903. PubMed ID: 32712153
[TBL] [Abstract][Full Text] [Related]
36. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
37. Human histone deacetylase 6 shows strong preference for tubulin dimers over assembled microtubules.
Skultetyova L; Ustinova K; Kutil Z; Novakova Z; Pavlicek J; Mikesova J; Trapl D; Baranova P; Havlinova B; Hubalek M; Lansky Z; Barinka C
Sci Rep; 2017 Sep; 7(1):11547. PubMed ID: 28912522
[TBL] [Abstract][Full Text] [Related]
38. Fluorescence Polarization-Based Competition Assays to Evaluate Histone Deacetylase 6 Inhibitors.
Ashraf QF; Quilates EJ; Olaoye OO; de Araujo ED; Gunning PT
Methods Mol Biol; 2023; 2589():481-492. PubMed ID: 36255644
[TBL] [Abstract][Full Text] [Related]
39. HDAC4 blocks autophagy to trigger podocyte injury: non-epigenetic action in diabetic nephropathy.
Wei Q; Dong Z
Kidney Int; 2014 Oct; 86(4):666-8. PubMed ID: 25265947
[TBL] [Abstract][Full Text] [Related]
40. ATP13A2 facilitates HDAC6 recruitment to lysosome to promote autophagosome-lysosome fusion.
Wang R; Tan J; Chen T; Han H; Tian R; Tan Y; Wu Y; Cui J; Chen F; Li J; Lv L; Guan X; Shang S; Lu J; Zhang Z
J Cell Biol; 2019 Jan; 218(1):267-284. PubMed ID: 30538141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
